SLB N.V. vs Takeda Pharmaceutical Company Limited
Market cap comparison over time
SLB N.V.
$73.9B
Rank #216
Takeda Pharmaceutical Company Limited
$74.9B
Rank #213
Market Cap Over Time
Key Moments
- Takeda Pharmaceutical Company Limited overtook SLB N.V. by 2001
- SLB N.V. overtook Takeda Pharmaceutical Company Limited by 2003
- Takeda Pharmaceutical Company Limited overtook SLB N.V. by 2020
- SLB N.V. overtook Takeda Pharmaceutical Company Limited by 2021
- Takeda Pharmaceutical Company Limited overtook SLB N.V. by 2026
Year-by-Year Comparison
| Year | SLB N.V. | Takeda Pharmaceutical Company Limited | Leader |
|---|---|---|---|
| 2026 | $73.9B | $74.9B | Takeda Pharmaceutical Company Limited |
| 2025 | $56.3B | $50.3B | SLB N.V. |
| 2024 | $54.6B | $41.6B | SLB N.V. |
| 2023 | $72.4B | $38.6B | SLB N.V. |
| 2022 | $73.1B | $37.6B | SLB N.V. |
| 2021 | $40.5B | $27.3B | SLB N.V. |
| 2020 | $28.8B | $31.2B | Takeda Pharmaceutical Company Limited |
| 2019 | $50.9B | $34.2B | SLB N.V. |
| 2018 | $43.4B | $28.0B | SLB N.V. |
| 2017 | $78.6B | $46.8B | SLB N.V. |
| 2016 | $95.3B | $34.2B | SLB N.V. |
| 2015 | $77.6B | $41.4B | SLB N.V. |
| 2014 | $92.3B | $33.1B | SLB N.V. |
| 2013 | $95.9B | $30.8B | SLB N.V. |
| 2012 | $72.9B | $23.7B | SLB N.V. |
| 2011 | $70.7B | $19.8B | SLB N.V. |
| 2010 | $85.4B | $22.3B | SLB N.V. |
| 2009 | $65.7B | $20.5B | SLB N.V. |
| 2008 | $41.9B | $23.7B | SLB N.V. |
| 2007 | $96.5B | $32.5B | SLB N.V. |
| 2006 | $61.4B | $39.6B | SLB N.V. |
| 2005 | $46.8B | $30.4B | SLB N.V. |
| 2004 | $31.9B | $24.2B | SLB N.V. |
| 2003 | $25.8B | $19.6B | SLB N.V. |
| 2002 | $19.5B | $22.5B | Takeda Pharmaceutical Company Limited |
| 2001 | $25.1B | $26.6B | Takeda Pharmaceutical Company Limited |
| 2000 | $36.0B | $30.0B | SLB N.V. |